Tyche Wealth Partners LLC Makes New Investment in MetLife, Inc. (NYSE:MET)

Tyche Wealth Partners LLC purchased a new position in MetLife, Inc. (NYSE:MET) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,871 shares of the financial services provider’s stock, valued at approximately $256,000.

A number of other large investors have also added to or reduced their stakes in MET. Norges Bank bought a new stake in MetLife in the 4th quarter worth $444,205,000. Pzena Investment Management LLC boosted its stake in shares of MetLife by 118.1% during the 3rd quarter. Pzena Investment Management LLC now owns 10,108,992 shares of the financial services provider’s stock valued at $635,957,000 after purchasing an additional 5,474,449 shares in the last quarter. Moneta Group Investment Advisors LLC bought a new stake in shares of MetLife during the 4th quarter valued at about $234,761,000. DekaBank Deutsche Girozentrale boosted its stake in shares of MetLife by 806.2% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 1,607,195 shares of the financial services provider’s stock valued at $100,152,000 after purchasing an additional 1,429,840 shares in the last quarter. Finally, Ensign Peak Advisors Inc boosted its stake in shares of MetLife by 309.7% during the 1st quarter. Ensign Peak Advisors Inc now owns 1,364,265 shares of the financial services provider’s stock valued at $95,881,000 after purchasing an additional 1,031,277 shares in the last quarter. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Down 0.0 %

Shares of MetLife stock opened at $68.92 on Thursday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market capitalization of $49.83 billion, a PE ratio of 37.66, a price-to-earnings-growth ratio of 0.52 and a beta of 1.04. MetLife, Inc. has a 52-week low of $48.95 and a 52-week high of $74.68. The company has a 50-day simple moving average of $70.98 and a two-hundred day simple moving average of $66.68.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). The firm had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, analysts anticipate that MetLife, Inc. will post 8.71 EPS for the current fiscal year.

Analyst Ratings Changes

MET has been the topic of a number of research reports. Piper Sandler lifted their target price on shares of MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and lifted their price target for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Keefe, Bruyette & Woods lifted their price target on shares of MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research report on Wednesday, April 10th. UBS Group lowered their price target on shares of MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research report on Monday, February 5th. Finally, Wells Fargo & Company lifted their price target on shares of MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $79.23.

Insider Activity

In other news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is owned by corporate insiders.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.